Sunhawk Vision Biotech, Inc. operates as a drug development company. It is engaged in the research and development of oligonucleotide drugs for ocular diseases based on the RNA therapy platform. The firm develops microRNA therapy in treating pediatric myopia. The company was founded by Su Hang Zhuo and Zhong Ling Liang on August 30, 2019 and is headquartered in Kaohsiung City, Taiwan.